Ratings by H.C. Wainwright (Debjit Chattopadhyay)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/8/2026 | Fate Therapeutics | FATE | Maintain | Buy (Buy) |
|
Details | ||
| 5/4/2026 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2026 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2026 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2025 | Fate Therapeutics | FATE | Upgrade | Buy (Neutral) |
1.29 (2.70) |
109.3% | Details | |
| 7/2/2025 | Fate Therapeutics | FATE | Maintain | Neutral (Neutral) |
|
Details | ||
| 6/2/2025 | Allogene | ALLO | Maintain | Buy (Buy) |
|
Details | ||
| 3/25/2025 | MacroGenics | MGNX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/19/2025 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2024 | Allogene | ALLO | Maintain | Buy (Buy) |
|
Details | ||
| 10/30/2024 | Allogene | ALLO | Maintain | Buy (Buy) |
|
Details | ||
| 9/18/2024 | MacroGenics | MGNX | Maintain | Neutral (Neutral) |
|
Details | ||
| 9/11/2024 | Stoke Therapeutics | STOK | Maintain | Buy (Buy) |
|
Details | ||
| 8/21/2024 | MacroGenics | MGNX | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/16/2024 | Fate Therapeutics | FATE | Maintain | Neutral (N/A) |
|
Details | ||
| 5/16/2024 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2024 | MacroGenics | MGNX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/11/2024 | MacroGenics | MGNX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/7/2024 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2024 | Bicycle Therapeutics | BCYC | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2024 | MacroGenics | MGNX | Downgrade | Neutral (Buy) |
17.35 (4.62) |
-73.37% | Details | |
| 1/19/2024 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2023 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2023 | Immunogen Inc. | IMGN | Downgrade | Neutral (Buy) |
16.06 (31.25) |
94.58% | Details | |
| 11/15/2023 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2023 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Immunogen Inc. | IMGN | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2023 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2023 | Immunogen Inc. | IMGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2023 | Immunogen Inc. | IMGN | Maintain | Buy (N/A) |
|
Details | ||
| 6/13/2023 | Immunogen Inc. | IMGN | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2023 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2023 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2023 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2023 | Fate Therapeutics | FATE | Downgrade | Neutral (Buy) |
5.55 (1.29) |
-76.76% | Details | |
| 12/30/2022 | Immunogen Inc. | IMGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2022 | Stoke Therapeutics | STOK | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2022 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2022 | Immunogen Inc. | IMGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2022 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2022 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2022 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2022 | Bicycle Therapeutics | BCYC | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2022 | Jounce Therapeutics | JNCE | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2022 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2021 | Fate Therapeutics | FATE | Upgrade | Buy (Neutral) |
72.79 (2.70) |
-96.29% | Details | |
| 3/30/2021 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2020 | Jounce Therapeutics | JNCE | New Coverage | Buy (N/A) |
6.89 (1.88) |
-72.71% | Details | |
| 8/24/2020 | Galapagos NV | GLPG | Downgrade | Neutral (Buy) |
137.16 (27.73) |
-79.78% | Details | |
| 6/26/2020 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2020 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2020 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 5/26/2020 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2020 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2020 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2020 | Sutro Biopharma | STRO | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2020 | Fate Therapeutics | FATE | New Coverage | Buy (N/A) |
28.75 (2.70) |
-90.61% | Details | |
| 5/12/2020 | Nektar Therapeutics | NKTR | Maintain | Neutral (N/A) |
|
Details | ||
| 4/17/2020 | Bicycle Therapeutics | BCYC | New Coverage | Buy (N/A) |
14.62 (4.24) |
-71% | Details | |
| 3/13/2020 | Allogene | ALLO | New Coverage | Buy (N/A) |
21.07 (2.08) |
-90.13% | Details | |
| 3/11/2020 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2020 | Voyager Therapeutics | VYGR | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2020 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2020 | Galapagos NV | GLPG | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2020 | Harpoon Therapeutics | HARP | New Coverage | Buy (N/A) |
13.29 (23.01) |
73.14% | Details | |
| 1/2/2020 | WAVE Life Sciences | WVE | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2019 | Immunogen Inc. | IMGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2019 | Synothorx Inc. | THOR | Downgrade | Neutral (Buy) |
67.71 (24.96) |
-63.14% | Details | |
| 12/3/2019 | Audentes Therapeutics | BOLD | Downgrade | Neutral (Buy) |
28.61 (2.50) |
-91.26% | Details | |
| 11/25/2019 | Zymeworks | ZYME | New Coverage | Buy (N/A) |
42.00 (26.14) |
-37.76% | Details | |
| 10/25/2019 | Stoke Therapeutics | STOK | New Coverage | Buy (N/A) |
22.86 (32.72) |
43.13% | Details | |
| 8/20/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2019 | AUTL | AUTL | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2019 | Precision BioSciences Inc. | DTIL | New Coverage | Buy (N/A) |
13.47 (7.86) |
-41.65% | Details | |
| 7/15/2019 | Galapagos NV | GLPG | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2019 | Global Blood Therapeutics | GBT | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2019 | Amicus Therapeutics | FOLD | New Coverage | Buy (N/A) |
11.66 (14.49) |
24.27% | Details | |
| 5/6/2019 | Immunogen Inc. | IMGN | Upgrade | Buy (Neutral) |
2.88 (31.25) |
985.07% | Details | |
| 3/28/2019 | Galapagos NV | GLPG | New Coverage | Buy (N/A) |
95.62 (27.73) |
-71% | Details | |
| 3/18/2019 | Audentes Therapeutics | BOLD | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2019 | Mersana | MRSN | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2019 | Immunogen Inc. | IMGN | Downgrade | Neutral (Buy) |
2.51 (2.88) |
14.74% | Details | |
| 2/20/2019 | Homology Medicines | FIXX | New Coverage | Buy (N/A) |
24.03 (0.93) |
-96.13% | Details | |
| 2/6/2019 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 1/2/2019 | Synothorx Inc. | THOR | New Coverage | Buy (N/A) |
17.38 (67.71) |
289.59% | Details | |
| 12/4/2018 | Global Blood Therapeutics | GBT | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2018 | Global Blood Therapeutics | GBT | Maintain | Buy (N/A) |
|
Details | ||
| 11/26/2018 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2018 | AUTL | AUTL | New Coverage | Buy (N/A) |
32.80 (1.60) |
-95.12% | Details | |
| 10/2/2018 | Avrobio Inc. | AVRO | Maintain | Buy (Buy) |
|
Details | ||
| 9/24/2018 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2018 | Mersana | MRSN | Maintain | (Neutral) |
|
Details | ||
| 9/17/2018 | Avrobio Inc. | AVRo | New Coverage | Buy (N/A) |
36.73 (16.53) |
-55% | Details | |
| 8/13/2018 | Jounce Therapeutics | JNCE | Maintain | Buy (N/A) |
|
Details |
